• 1. Design, synthesis, biological evaluation and molecular docking study of novel pyridoxine–triazoles as anti-Alzheimer's agents
  Tiyas Pal,Saipriyanka Bhimaneni,Abha Sharma,S. J. S. Flora RSC Adv. 2020 10 26006
• 2. Crystal structure, spectroscopic, DNA binding studies and DFT calculations of a Zn(ii) complex
  Satyajit Mondal,Moumita Chakraborty,Antu Mondal,Bholanath Pakhira,Subhra Kanti Mukhopadhyay,Avishek Banik,Swaraj Sengupta,Shyamal Kumar Chattopadhyay New J. Chem. 2019 43 5466
• 3. Endoplasmic reticulum targeting tumour selective photocytotoxic oxovanadium(iv) complexes having vitamin-B6 and acridinyl moieties
  Samya Banerjee,Akanksha Dixit,Anjali A. Karande,Akhil R. Chakravarty Dalton Trans. 2016 45 783
• 4. 34. Contributions to the chemistry of pyridine. Part II. 3- and 5-Hydroxy-2-methylpyridine, and the condensation of 5-hydroxy-2-methylpyridine with formaldehyde in alkaline medium
  T. Urbanski J. Chem. Soc. 1947 132
• 5. 838. Synthetical experiments in the B group of vitamins. Part IV. A synthesis of pyridoxine
  A. Cohen,J. W. Haworth,E. G. Hughes J. Chem. Soc. 1952 4374

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Methylpyridines

Introduction to 3-Hydroxy-2-methylpyridine (CAS No. 1121-25-1)

3-Hydroxy-2-methylpyridine, identified by the chemical compound code CAS No. 1121-25-1, is a significant heterocyclic organic compound that has garnered considerable attention in the field of pharmaceutical chemistry and biochemical research. This compound, characterized by a pyridine core with hydroxyl and methyl substituents, exhibits unique structural and functional properties that make it a valuable intermediate in the synthesis of various biologically active molecules. The presence of both polar hydroxyl and non-polar methyl groups imparts distinct solubility characteristics and reactivity patterns, which are exploited in multiple synthetic pathways.

The structure of 3-Hydroxy-2-methylpyridine features a six-membered aromatic ring containing nitrogen, with hydroxyl (-OH) attached to the third carbon and a methyl (-CH?) group at the second carbon position. This arrangement contributes to its ability to participate in hydrogen bonding interactions, enhancing its solubility in polar solvents while maintaining some lipophilicity due to the methyl group. Such properties are particularly advantageous in drug design, where balancing hydrophilic and hydrophobic interactions is crucial for achieving optimal pharmacokinetic profiles.

In recent years, 3-Hydroxy-2-methylpyridine has been extensively studied for its potential applications in medicinal chemistry. Its pyridine scaffold is a common motif in many pharmacologically active compounds, including antibiotics, antivirals, and anticancer agents. The hydroxyl group provides a site for further functionalization, allowing chemists to tailor the molecule's properties for specific biological targets. For instance, modifications at this position can influence metabolic stability, binding affinity, and overall bioavailability of derived compounds.

One of the most compelling aspects of 3-Hydroxy-2-methylpyridine is its role as a precursor in the synthesis of more complex molecules. Researchers have leveraged its structural framework to develop novel therapeutic agents with enhanced efficacy and reduced side effects. Recent studies have highlighted its utility in generating derivatives that exhibit potent inhibitory activity against enzymes implicated in inflammatory diseases and cancer progression. The ability to modify both the hydroxyl and methyl substituents offers a high degree of flexibility in designing molecules with tailored pharmacological profiles.

The synthesis of 3-Hydroxy-2-methylpyridine typically involves multi-step organic reactions starting from readily available pyridine derivatives. Advanced synthetic methodologies have been developed to improve yield and purity, ensuring that researchers have access to high-quality starting materials for their investigations. Techniques such as catalytic hydrogenation, oxidation-reduction reactions, and regioselective functionalization are commonly employed to construct the desired molecular architecture efficiently.

From a biochemical perspective, 3-Hydroxy-2-methylpyridine has shown promise as a key intermediate in enzymatic pathways relevant to metabolic diseases. Its structural similarity to certain natural products has prompted investigations into its potential role as a substrate or inhibitor for specific enzymes. This has opened up new avenues for understanding disease mechanisms and developing targeted therapies. Additionally, the compound's ability to interact with biological macromolecules has made it a valuable tool in structure-activity relationship (SAR) studies aimed at optimizing drug candidates.

The pharmaceutical industry has taken note of 3-Hydroxy-2-methylpyridine's versatility and is exploring its incorporation into next-generation drug candidates. Its dual functionality—hydroxyl for hydrogen bonding interactions and methyl for lipophilic effects—makes it an attractive building block for molecules designed to interact with biological targets in specific ways. As research progresses, it is expected that new synthetic routes will be developed further enhancing access to this compound and its derivatives.

Moreover, advancements in computational chemistry have accelerated the discovery process by enabling virtual screening of potential derivatives of 3-Hydroxy-2-methylpyridine before experimental synthesis. Machine learning models trained on large datasets can predict biological activities with high accuracy, allowing researchers to prioritize promising candidates efficiently. This interdisciplinary approach combines experimental expertise with computational power to streamline drug development pipelines.

The environmental impact of synthesizing 3-Hydroxy-2-methylpyridine is another area of growing interest. Efforts are underway to develop greener synthetic methods that minimize waste generation and reduce reliance on hazardous reagents. Continuous flow chemistry techniques have emerged as particularly promising alternatives due to their inherent efficiency and scalability while reducing environmental footprint—a critical consideration as regulatory pressures on sustainable practices intensify across industries.

In conclusion,3-Hydroxy-2-methylpyridine (CAS No.,1121-25-1) represents more than just an intermediate—it embodies innovation at the intersection of organic synthesis biology medicine . With ongoing research uncovering new applications ,this compound continues solidify itself indispensable tool modern pharmaceutical landscape . As science advances ,expect continued exploration expand therapeutic possibilities offered by unique chemical nature .

• 90724-46-2(3-Hydroxy-2-methylpyridineHydrochloride)
• 175170-53-3(2,5-dimethylpyridin-3-ol)
• 763869-70-1(3,5-Pyridinediol,2-methyl-)
• 1121-78-4(6-methylpyridin-3-ol)
• 1122-43-6(2,6-dimethylpyridin-3-ol)
• 71595-24-9(3-Pyridinol, 2,6-dimethyl-, hydrochloride)
• 55780-69-3(2-METHYLPYRIDIN-3-OL)
• 27296-76-0(2,4-Dimethyl-3-hydroxypyridine)
• 26395-26-6(3-Methoxy-2-methylpyridine)
• 72133-22-3(3-Pyridinol, 6-methyl-, potassium salt (1:1))